1h Free Analyst Time
The genome editing market is forecasted to grow by USD 7.23 bn during 2023-2028, accelerating at a CAGR of 15.88% during the forecast period. The report on the genome editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rapid technological advancements in genome editing, increasing demand for personalized medicine, and the emergence of novel gene editing platforms.
The genome editing market is segmented as below:
By End-user
- Pharmaceutical and biotechnology companies
- Academic institutes and research laboratories
- CRO
By Delivery Mode
- Ex-vivo
- In-vivo
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the genome editing market covers the following areas:
- Genome editing market sizing
- Genome editing market forecast
- Genome editing market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by End-user
7 Market Segmentation by Delivery Mode
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global genome editing market: AstraZeneca PLC, Caribou Biosciences Inc., Cellectis SA, Cibus, Danaher Corp., Editas Medicine Inc., Egenesis, GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer Inc, Precision BioSciences Inc., Sangamo Therapeutics Inc., Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the rise of CRISPR-based diagnostics."
According to the report, one of the major drivers for this market is the rapid technological advancements in genome editing.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca PLC
- Caribou Biosciences Inc.
- Cellectis SA
- Cibus
- Danaher Corp.
- Editas Medicine Inc.
- Egenesis
- GenScript Biotech Corp.
- Horizon Discovery Ltd.
- Intellia Therapeutics Inc.
- Lonza Group Ltd.
- Merck KGaA
- New England Biolabs Inc.
- OriGene Technologies Inc.
- PerkinElmer Inc
- Precision BioSciences Inc.
- Sangamo Therapeutics Inc.
- Takara Bio Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
